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Abstract
Glioma surgery has been the main component of glioma treatment for decades. The surgi-
cal approach changed over time, making it more complex and more challenging. With 
molecular knowledge and diagnostic improvement, this challenge became maximally safe 
resection of tumor, which resulted in prolonged overall survival, progression-free period, 
and a better quality of life. Today, the standard glioma treatment includes maximally safe 
resection, if feasible, administration of temozolomide, radiotherapy, and chemotherapy. 
Surgical resection is performed as subtotal resection, gross total resection, and supratotal 
resection. Subtotal resection is the resection where a part of tumor is left. Gross total resec-
tion is a complete removal of the magnetic resonance imaging (MRI) visible tumor tissue. 
Supratotal resection is performed as gross total resection with excising the MRI visible 
tumor tissue borders into the unaffected brain tissue. Before we make final decision on 
which type of resection should be performed, many factors have to be considered. The 
main question has to be answered: what the actual impact of resection on the progression 
of glioma is and what the functional risk of resection is.
Keywords: glioma biopsy, subtotal resection, gross total resection, supratotal resection, 
oncofuntional balance
1. Introduction
Glioma is the most frequent malignant tumor of the brain, with a high mortality as the 
grade of glioma gets higher [1]. World Health Organization in 2016 classified glioma into 
four grades, where I and II grades are classified as low grade glioma and III and IV grades 
as high grade glioma [2]. Glioma surgery is one of the most common and challenging 
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surgeries for every neurosurgeon. The history of glioma surgery changed during the past 
century following all technical progresses. One of the biggest technical improvements 
started with the discovery of nuclear magnetic resonance in the 1950s, now known as mag-
netic resonance imaging [3]. After MRI introduction, the concept of maximal MRI visible 
tumor resection started to be the standard approach to glioma surgery. Nevertheless, this 
concept had a significant rate of morbidity, and it stranded to be valid for decades. During 
the past 25 years, the concept of surgical removal of gliomas has changed from a maximally 
aggressive for high grade glioma to minimally invasive but maximally efficient resection. 
The concept for low grade glioma changed also from “watch and wait” to active surgical 
treatment [4].
In the course of years, subtotal resection (STR) and gross total resection (GTR) evolved to 
supratotal resection, which became the surgical option especially for low grade glioma 
in the eloquent area and younger patients. With supratotal resection, neurosurgeons 
are trying to utilize minimally invasive surgery for the preservation of life quality as 
much as possible, but resecting most of tumor tissue using brain monitoring techniques, 
intraoperative imaging, awake surgery options, etc. The overall survival period with this 
approach was extended. As the new surgical concept, supratotal resection, which is actu-
ally also aggressive but selective, controlled, and monitored approach, over the years 
confirmed the highest level of general development of glioma surgery. In this respect, 
supratotal resection is probably becoming the most important part of state of the art in 
glioma management generally, but we are waiting for the results of big clinical trials. 
When the tumor infiltrates eloquent brain areas the challenge is how much to resect in 
balance of maximal safe resection and possible neurological deficit or worsening of func-
tional status [4].
In this review, we are going to discuss surgical options for glioma treatment and the impact 
of it on the patient’s life.
2. Different surgical options
Gliomas represent 30% of all brain tumors and 80% of all malignant brain tumors [1]. The 
origin of gliomas are the transformed glioma cells of the central nervous system. Gliomas 
can be classified by cell type, localization, and grade. The grade classification is performed by 
World Health Organization (WHO) in 2016 and widely used [2].
There are four grades of gliomas:
Grade I—pilocytic astrocytoma;
Grade II—diffuse astrocytoma, oligodendroglioma;
Grade III—malignant glioma: anaplastic astrocytoma, anaplastic oligodendroglioma;
Grade IV—glioblastoma multiforme (IDH wild type and mutant), diffuse midline glioma, H3 
K27M-mutant.
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Grade I and II gliomas are classified as low grade glioma (LGG) and grade III and IV as high 
grade glioma (HGG). Surgical treatment options are different for every group of gliomas, 
LGG and HGG, due the glioma life cycle [2].
2.1. Surgical techniques
In this review, we will present contemporary surgical techniques used in treatment of both 
glioma groups: LGG and HGG and the impact on patient’s life. Surgery remains the core 
treatment for management of gliomas. Surgical resection of pathological tumor mass, almost 
nonfunctional brain region, is common, standard, and the oldest neurosurgical approach to con-
temporary neuro-oncology. Historically, glioma surgery was a controversial topic, but many 
recent studies have demonstrated the crucial place of glioma resection in the management of 
low and high grade gliomas [5]. Concerning glioma surgery, there are two big questions: what 
the actual impact of resection is on progression of glioma and what the functional risk of it is 
[6]. To improve the outcomes of these two questions in past decades, a huge improvement 
has been made in intraoperative techniques (neuronavigation, intraoperative MRI, intraopera-
tive ultrasound, stimulation mapping techniques, and fluorescence-guided surgery; Figure 1) 
[7, 8]. These techniques were developed to maximize the resection of glioma and preserve or 
improve the quality of life [6, 7]. Before glioma surgery, the neurosurgeon must calculate all 
benefits and possible hazards which could influence on morbidity, mortality, and quality of 
the rest of life.
There are few surgical options based on glioma type:
• glioma biopsy.
• subtotal resection.
• gross total resection.
• supratotal resection.
Figure 1. Typical intraoperative arrangement of the patient who undergoes tumor resection and the neurosurgeon, in 
the early stage of glioma surgery, immediately before dural opening. Microscope is positioned close to the surgeon’s 
left arm and neuronavigation tool is in front (picture on the left). After the opening of the dura, characteristic findings 
of differently colored glioma affecting the brain cortex are presented. Tumor tissue bulks over the dural edge; it is 
obviously white-grayish and much lighter, with strange pathological vascularization (picture on the right).
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2.1.1. Glioma biopsy
Glioma biopsy is the standard procedure for taking tissue samples of tumors with a minimally 
invasive approach. It consists of taking a sample of tissue through a minimum opening of the 
skull. Biopsy indications are tumors in difficultly accessible brain zones, multicenter lesions, 
and pathology where it is advisable to establish a pathohistological diagnosis, which will then 
determine further surgical or nonsurgical treatment (e.g., whether it is tumor glioma or lym-
phoma; the former will then undergo resection, while the latter is mainly nonsurgically treated). 
On the other hand, very advanced gliomas and gliomas in the elderly who are not candidates 
for a more aggressive approach (open surgery) are also indications for biopsy. Minimally inva-
sive approaches have been favored for a long time in neurosurgery for glioma resection.
2.1.1.1. Frame-based stereotaxis
Today, Leksell G frame is still the most widely used, consisting of two parts—one fixed quad-
rangular and the other moving, the so-called arc. The fixed part consists of four graduated 
rods. On the right or left side of the patient, there is a diagonal bar in the form of the letter “N” 
that connects the corners.
Of the four basic geometric systems used in frame-based navigation systems, the “arc radius” 
system is the most commonly used, which is the base of the Leksell frame. The principle of the 
C arc is based on the ability to reach the center of the C arc from all directions by moving the 
probe along the radius of the frame. The frame itself is fixed on the patient’s head, while the C 
arc is a movable part with the possibility of penetrating with a puncturing needle through any 
point on the convexity of the skull. The advantages of the Leksell frame design are the ability 
to reach any intracranial point with great precision and the ability to use it directly under 
the control of CT or MRI. One of the disadvantages is the bulkiness of the device itself, the 
obstruction of the operating field, and the “non-real time” procedure if there is no radiological 
supervision (CT or MRI).
By setting up the frame and the effect of the CT scanning, the center is first marked in ante-
rior–posterior direction. The center is observed on axial CT scans in the form of the letter X by 
joining the frame corners. On the vertical plane, the center is marked by pulling the corner line 
through the mid-point of the letter “N.” After defining the center, the target point is defined 
in relation to the geometric center of the frame and it can be accurately calculated, after which 
the C arc is moved and the probe is placed in the center of the lesion.
2.1.1.2. Frameless stereotaxis
Next evolutionary step in the development of stereotaxis was frameless stereotaxis. Frame-
based stereotaxis is a clearly defined relationship between two coordinate systems (preopera-
tive and intraoperative) and a precise position in relation to the planned procedure without 
further need for determining coordinates. Frameless stereotaxis, unlike frame-based, uses 
“point pair” registration to establish a relationship between preoperative images and surgical 
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field or coordinate systems relative to preoperative images and patients during surgery. To 
connect these two coordinate systems, “registration” is necessary to establish a common rela-
tionship between two coordinate systems [9].
The frameless system consists of two parts, an infrared scanner and a dynamic frame, that is 
fixed to the Mayfield holder. The dynamic scanner transmits the coordination system data to 
the operating field and integrates them with software with preoperative images. The dynamic 
framework requires at least three fixed registration points (nasion, lateral cannula, frontal 
tuber, and tragus). In the further course, an additional multipoint registration on the curva-
ture of the skull is used for the purpose of co-registration and refining the matching of the two 
coordinating systems. Registration is performed by marker or laser. Once the registration has 
been made, it is necessary to carry out a check for early identification of errors. The advan-
tages of the frameless system are ease of use, as well as intraoperative possibility, altering the 
route or plan without the need for additional CT scanning, not taking up a large space, the 
possibility of absolute freedom of manipulation of the operating field, and no preoperative 
planning and determination of the coordination point on CT or MRI.
As the leading flaw of the frameless system, there is a decrease in precision compared to 
frame based, most likely because of less defined registration points in comparison to clearly 
defined points. However, these deviations from the target point in the brain do not exceed 
a value of 2–5 mm; they are expected and they are generally accepted when executing the 
procedure.
2.1.1.3. Navigation-guided glioma biopsy
Most important indications for neuronavigation in glioma surgery are:
a. Neuronavigation driven resections, subtotal resections, and reduction of gliomas (deter-
mination of tumor margins, edges of craniotomy, as well as limitations of the form and 
length of skin incisions)
b. Neuronavigational inducement of glioma biopsy
• early diagnosis with minimal risk
• deep lesions (thalamic gliomas, basal ganglia etc.)
• patients with a high operative risk in case of prolonged anesthesia or those with 
advanced diseases and poor prognosis compared to co-morbidity
• multiple lesions
• patients who reject the proposed surgery for resection
• patients with "unsafe" radiological diagnosis and suspicion of infectious or demyelinat-
ing disease
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c. Setting the catheter into tumor cavity
• cyst drainage
• intratumoral chemotherapy
• intratumoral radiotherapy
Unrelated to the use of neuronavigation in oncology or the treatment of gliomas, neuronavi-
gation can be used in ventriculostomy, electrode placement for deep brain stimulation, endo-
scopic neurosurgery, etc.
2.1.1.4. The present, challenges, and future of biopsy
One of the disadvantages of the established stereotaxy is deviation during the procedure and 
its execution at the present time in the MRI or CT preoperative images. Currently, efforts 
are being made to overcome the problem by real-time MRI-induced biopsy with promising 
results [10, 11]. In certain cases, when we have an extremely small tumor, the precision of 
biopsy is questionable with disappointing pathohistological results. Today, microelectrodes 
are used to do the microrecording of the brain electrical potential on the biopsy path and in 
the target tumor zone with the absence of electrical potentials, performing biopsy by the “real 
time” method and increasing safety and precision [10].
Since fluorescence 5 ALA has already found its use in tumor surgery and increased radicalism 
of resection, it is also applied in biopsy; a decrease in negativity of results was observed [11].
Because of the existence of brain blood barriers and inadequate chemotherapeutic penetration 
of brain tumor, convection-enhanced delivery is developed, which represents a modality of 
combined surgical and colon tumor treatment. Locally, the medicine (chemotherapeutic) is 
placed into the brains of rats by using a frameless catheter; it is used in the treatment of diffuse 
brain stem gliomas [12].
2.1.2. Subtotal resection
Glioma resection in which a portion of tumor can still be seen in postoperative images is 
called subtotal resection (STR). STR should be performed only when it is not possible to per-
form gross total resection (GTR). To have better results of STR, tumor mass must be removed 
as much as possible to preserve functionality of the patient and quality of life. All technical 
supports should be used to optimize STR. Intraoperative MRI should be used in every STR to 
optimize glioma safe removal [8].
2.1.3. Gross total resection
Some mathematical modeling studies estimated that at least 78% of preoperative tumor vol-
ume must be resected to increase survival and resection brings an incremental benefit of up to 
98% [13]. The surgical resection technique that brings this benefit with clear margins is called 
gross total resection, Figures 2 and 3. Since the beginning of wide use of modern operative 
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techniques, the incidence of gross total resection has increased [8]. On the other hand, without 
technical development, microsurgical GTR of glioma cannot be always achieved because of 
the deep location of tumor, located in the eloquent regions, and/or both hemispheres spanned 
[14]. Aggressive GTR can lead to increased morbidity and complications without improving 
survival [15, 16]. GTR is shown to be an independent factor of overall survival (OS), but, 
in respect of STR, evidence is not clear for its benefit [6–8, 15]. Like for STR, in GTR also, 
intraoperative MRI and all technical supports should be used to have a better resection and to 
preserve the eloquent brain areas.
2.1.4. Supratotal resection
Surgical resection of pathological tumor mass, almost nonfunctional brain region, is common, 
standard, and the oldest neurosurgical approach to contemporary neuro-oncology. Historically, 
glioma surgery was a controversial topic, but many recent studies have demonstrated the crucial 
Figure 2. A 19-year-old male patient admitted to our department comatose, with Glasgow Coma Scale score—GCS 
4, with respiratory dysfunction (August 2015). Urgent surgery was performed with GTR, pathohistology confirmed 
LGG. Three weeks later, the patient was discharged from the department in good condition—awake, walking alone with 
Karnofsky score 80. Preoperative axial, sagittal, and coronal postcontrast T1-weighted MRI (A-C) show a huge tumor in 
the cerebellum, predominantly on the left side with adherence to the brain stem and propagation down to C2 (Siemens 
MRI Avanto 1.5 T). Two and a half years postoperative contrast T1-weighted MRI, in March 2018 (D–F), shows complete 
tumor resection with no signs of tumor rest or recurrence.
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place of glioma resection in the management of low and high grade gliomas [5]. Over time, the 
approach to glioma changed from minimally invasive biopsy to maximally possible resection 
(STR or GTR). Today, total resection changed from temporal lobectomy to very aggressive 
frontal lesion—paralesional resection of high grade glioma. In the past decade, supratotal 
resection became a popular approach technique for glioma resection. Supratotal resection 
includes, like GTR, a total tumor resection with radical resection of perilesional brain tissue, 
nonglioma region, Figure 4. Even after GTR, because of the infiltrative behavior of glioma, 
probably there are some cells left, which is the biggest challenge to a successful resection and 
increase in recurrence, OS, and progression-free survival (PFS) [5, 17]. With conventional MRI, 
it is almost impossible to estimate spatial extent of infiltrative glioma [5]. In low grade glioma, 
tumor cells are found up to 20 mm beyond MRI seen abnormalities, while in GBM, cells are 
found diffusely in the hemisphere on the GBM site, even contralaterally [17]. These cells lead 
to diffuse spread of tumor and its recurrence [5]. Visualization of these cells is beyond any 
known technique. With supratotal resection of the margins around tumor visible on FLAIR-
weighted MRI, there is a limited possibility of leaving residual cells. This resection impacts also 
on the history of malignant transformation of glioma, which occurs after diagnosis in 4-year 
Figure 3. An 11-year old girl with glial tumor in the posterior fossa producing hydrocephalus, admitted to the 
neurosurgical department with impairment of consciousness, walk and gait disturbance, fully dependent on parents 
(June 2015). Preoperative T1W axial, coronal, and sagittal contrast brain MRI (A–C) revealed a huge glial tumor, 
predominantly solid, mostly located in the left cerebellar hemisphere with partial involvement of the fourth ventricular 
floor and compression to the brain stem (low grade glioma). Two and half years of postoperative contrast T1W MRI 
shows no recurrence of tumor (D–F, March 2018). The child is in full condition without any neurological deficit.
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Figure 4. A 38-year old female patient admitted to our neurosurgical department after a large glioma was found in 
the right temporal region. The patient was with mild left-sided hemiparesis and dizziness (January 2016). Supratotal 
resection was done and tumor completely resected with 1 cm perilesional tissue. She was discharged from hospital 
5 days after the surgery without any neurological deficit. Chemotherapy (temozolomide) and the whole brain irradiation 
were done immediately. Brain MRI (A–C) was performed prehospitally, T2W axial sequence and T1W axial and coronal 
postcontrast sequence show extensive, solid cystic tumor located right temporoparietally, surrounded by peripheral 
edema with compression signs on the right side of the cerebral chamber and signs of mediosagital structure shift to the 
left. Twelve months after the surgery (March 2017), there was no recurrence on control MRI (middle row, pictures D-F). 
The same patient 16 months after the surgery (G–I). It was IDH negative glioblastoma multiforme, Grade IV, wild type. 
Although a complete neurosurgical resection was performed, recurrence was revealed on 16 months follow-up MRI 
(July 2017), not even on the site of the previous surgery but on the contralateral side as multicentric lesion in the brain 
stem. MRI T1W axial postcontrast sequence showed multicentric lesions in the left cerebellar pedunculate area, left 
parietal paraventricular, and left parietal supraventricular areas. The postoperative area on the right did not show any 
recurrence of the primary tumor. Despite all given therapy, the patient died 17 months after the surgery. This example 
confirms the thesis that glioblastomas are a diffuse disease, and probably, even after extremely vast surgery, tumor 
reoccurrence will occur relatively soon. IDH, Isocitrate dehydrogenase.
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periods on average [5]. Currently, a randomized controlled clinical trial of supratotal resection 
for all grade gliomas in noneloquent areas is being conducted with 120 participants; primary 
results are expected soon (2 years OS, PFS, and Karnofsky Performance Score (KPS)) [18]. The 
evolution of supratotal surgery from gross total to supratotal was possible due a number of 
technological advances (light microscope, microneurosurgical tools, magnetic resonance imag-
ing, neuro-navigation, brain mapping, 5-ALA fluoroscency technique, tractography, etc.). 
Supratotal resection, concerning recently published findings of a few independent authors, 
resulted in better survival of glioma patients [13, 19].
2.2. Low grade glioma surgical options
For grade II glioma, the recommended treatment is maximally safe resection, with or without 
radiotherapy followed by procarbazine, lomustine, and vincristine administration or temo-
zolomide plus radiotherapy followed by temozolomide depending of glioma features [20]. 
When it comes to low grade glioma in the meta-analysis, 5-year OS was markedly increased 
after resection of low grade glioma, increasing from 50–70% in STR to 80–95% in GTR [7]. GTR 
has superiority over STR and biopsy with increased OS and PFS [6, 21, 22]. But in another 
large study, they did not find any difference between STR and GTR in 5-year OS [23]. The 
impact of STR on OS must be more clearly defined. One study has shown that in younger 
patients with supratentorial low grade glioma, OS after GTR at 2 and 5 years was 99 and 93%, 
respectively. The PFS rates at 2 and 5 years were 82 and 48%, respectively [13].
In addition to greater OS GTR for low grade gliomas, it may impact on alerting process from 
low grade to high grade glioma [7]. In children after GTR, low grade glioma often does not 
need any further therapy, with 10 years OS rates of 90% or greater, with rare tumor recur-
rences [24]. In a study including patients with supratotal resection of low grade glioma with 
11-year mean follow up, malignant transformation to high grade glioma did not occur. In the 
control group of total resection, 24% of the patients had malignant transformation from low to 
high grade glioma (p = 0.037) [19]. These promising results come from a pilot study including 
only 16 patients with performed supratotal resection; a larger study is needed to give a more 
relevant overview of the behavior of lower grade glioma after supratotal resection.
2.3. High grade glioma surgical options
Recommended treatment for grade III and IV glioma, glioblastoma multiforme (GBM), 
includes maximally safe resection, if feasible, administration of temozolomide with combina-
tion of radiotherapy and chemotherapy depending of favorable and unfavorable prognostic 
factors and glioma features [20]. The median OS for GMB is 15 months and for grade III tumors 
between 3.5 and 10 years [14, 25]. In surgical treatment, STR shows better OS compared to 
biopsy without increasing morbidity [8]. As shown in a meta-analysis of 12,607 high-graded 
glioma in elderly patients, biopsy OS vs. STR was 5.71 months vs. 8.68 months, respectively, 
with lower morbidity rate and longer progression free survival in STR patients [21]. In studies 
assessing the extent of resection (EOR) in high-grade glioma, in the so-called volumetric stud-
ies, STR showed a shorter OS of 2 to 8 months; in nonvolumetric studies, OS was also shorter 
by 0.9 to 8 months [7]. In their study, Chaichana et al. showed that residual volume and EOR 
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are independent values for OS and GBM recurrence. They found that the residual volume of 
<2 cm3 with 95% resection has the greatest reduction in death in GBM patients [14]. Because of 
this EOR feature, it is mandatory to perform GTR always when possible, depending on tumor 
location and quality of life after GTR. GTR has superiority over STR in elderly patients with 
high grade glioma. GTR resulted in better OS, PFS, and Karnofsky performance score [21]. In 
children with mean age of 11 years, GTR of high grade glioma resulted in better OS than STR, 
3.4 years vs. 1.6 years, respectively. Female patients with GTR also had a better OS than male 
patients, 8.1 years vs. 2.4 years, respectively [26]. Concerning higher grade glioma, supratotal 
resection can have some benefits. In a study of Li et al. of 876 patients who had a GTR (100% 
EOR), 643 underwent resection of T2 FLAIR abnormality region. Approximately, 18% of them 
had negative EOR due to postoperative edema, and in positive patients—more than 53.21%—
FLAIR resection was associated with improved OS compared with patients with less than 
53.21% FLAIR resection (20.7 months vs. 15.5 months, p < 0.001) [27]. With supratotal resec-
tion, the usage of chemotherapy and radiotherapy was reduced after supratotal resection.
3. Surgical technique and oncofunctional balance
As mentioned before, the overall technical development has made supratotal resection pos-
sible, with adequate balance between maximal resection of tumor with paralesional region 
and functional consideration for the eloquent region of the brain. To increase the extent of 
resection, before surgery, functional MRI, white-matter tractography is performed; during 
the surgery, intraoperative MRI or ultrasound and 5-ALA-guided resection are used [5]. All 
these techniques give a rich fund of information, but when the leak of functional information 
occurs, it signals to us that, while operating, we approached the eloquent brain areas resec-
tion [5, 28]. Electrostimulation mapping during supratotal resection is the most important 
technique used to identify cortical areas and subcortical pathways involved in eloquent func-
tions (especially motor, sensory, language, and cognitive functions) [5, 28, 29]. The usage of 
electrostimulation in humans started in the 19th century, but the first one in neuro-oncology 
was used in the 90s of the 20th century by Mitchel Berger. He applied electrostimulation for 
the mapping of eloquent cortical areas. Hugues Duffau extended and summarized the indica-
tion of electrostimulation usage at cortical and subcortical levels intraoperatively [29].
Intraoperative bipolar electrostimulation mapping has become a mandatory tool in neuro-
oncology allowing to:
a. study real time individual cortical functional organization;
b. study subcortical connectivity along resection;
c. perform resection according to individual corticosubcortical functional boundaries;
d. make a better neuro-oncological impact, with preservation of the quality of life [28, 30].
With intraoperative electrostimulation, resection is extended into the regions which were con-
sidered inoperable. By this extension, a great functional outcome has been documented with 
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more than 95% of patients recovering to the normal neurological status in 3 months after the 
surgery, while some patients had improvement in comparison with their preoperative status. 
In respect of epilepsy, 80% of the patients with preoperative epilepsy did not report it after the 
surgery [28]. Electrostimulation is a safe, easy, accurate, and reliable technique of individual-
ization of resection for each patient aiming to achieve the “oncofunctional balance.”
“Oncofunctional balance” is the term used by Duffau to illustrate the approach to glioma 
resection through interaction with the patient to determine the best therapeutic sequence 
according to the patient’s needs [31]. Intraoperative electrostimulation is used during the 
awake glioma surgery, which allows studying interactions between the natural history of 
tumor and the brain reorganization. With this approach, we are able to preserve the eloquent 
functions of the brain. Each patient who will undergo supratotal resection should be informed 
about possible deterioration of the eloquent functions, which of them are most important 
to him/her to achieve maximal oncofunctional balance. With this approach, glioma surgery 
becomes an individual surgery, especially designed for each patient.
4. Conclusion
Glioma surgery is one of the most impacting surgical interventions to human health, life, and 
quality of it. As the molecular knowledge of the life circle of gliomas and techniques improves, 
it increases our dream that potential curing glioma will come true. Today, the most important 
treatment option for preserving the quality of life and overall survival is surgical resection. If 
possible, maximal surgical resection with preservation of neurological functions should be first 
option in treatment of low and high grade glioma. The resection should be performed with the 
balance of maximal resection and maximal preservation or improvement of the quality of life. 
The new promising approach in glioma surgery is supratotal resection with the use of electro-
stimulation mapping, which makes glioma surgery an individual treatment option for each 
single patient. But there is a need of more clinical evidence to make supratotal resection widely 
used. Supratotal resection today is still reserved for individual cases. However, if it is impos-
sible to perform GTR, then STR should be performed. Glioma biopsy is only the last option 
to confirm the diagnosis for gliomas without possible surgical resection as treatment option.
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